U2Bio Co., Ltd. (KOSDAQ:221800)
5,140.00
-350.00 (-6.38%)
At close: Dec 5, 2025
78.78% (1Y)
| Market Cap | 69.62B |
| Revenue (ttm) | 25.59B |
| Net Income (ttm) | -2.99B |
| Shares Out | 13.54M |
| EPS (ttm) | -265.03 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 529,287 |
| Average Volume | 4,858,023 |
| Open | 5,510.00 |
| Previous Close | 5,490.00 |
| Day's Range | 5,110.00 - 5,570.00 |
| 52-Week Range | 2,370.00 - 7,900.00 |
| Beta | -0.20 |
| RSI | 48.50 |
| Earnings Date | n/a |